CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-15 | BLECH ISAAC Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | Crane Rosemary A Director | Exercise or conversion | +10,000 | 10,000 | ||
| 2019-03-15 | Crane Rosemary A Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | BARER SOL J Director | Exercise or conversion | +20,000 | 678,075 | ||
| 2019-03-15 | BARER SOL J Director | Exercise or conversion · Restricted Stock Units | −20,000 | 0 | ||
| 2018-08-14 | Macdonald R. Loch Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | Crane Rosemary A Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | Ratcliffe Liam Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | LOUGHLIN JAMES J Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | BLECH ISAAC Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | MARCHIO ALBERT N II Chief Accounting & Adm Officer | Grant or award · Restricted Stock Units | +41,666 | 41,666 | ||
| 2018-08-14 | Saik Andrew Chief Financial Officer | Grant or award · Restricted Stock Units | +82,999 | 82,999 | ||
| 2018-08-14 | Wyant Alyssa SVP Regulatory Affairs | Grant or award · Restricted Stock Units | +49,766 | 49,766 | ||
| 2018-08-14 | Spiegel Robert J. Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-08-14 | BARER SOL J Director | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2018-08-14 | Faleck Herbert J Chief Medical Officer | Grant or award · Restricted Stock Units | +59,833 | 59,833 | ||
| 2018-08-14 | Leuthner Brian A President and CEO | Grant or award · Restricted Stock Units | +169,032 | 169,032 | ||
| 2018-08-14 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Grant or award · Restricted Stock Units | +49,766 | 49,766 | ||
| 2018-06-19 | BLECH ISAAC Director | Grant or award · Stock Option (Right To Purchase) | +20,000 | 20,000 | ||
| 2018-06-19 | Ratcliffe Liam Director | Grant or award · Stock Option (Right To Purchase) | +20,000 | 20,000 |
Page 8 of 18 · 346 trades